Aclaris Therapeutics, Pediatrix Therapeutics Ink License Deal For ATI-1777 In Greater China

RTTNews | Pred 918 dňami
Aclaris Therapeutics, Pediatrix Therapeutics Ink License Deal For ATI-1777 In Greater China

(RTTNews) - Biopharmaceutical company Aclaris Therapeutics, Inc. (ACRS) and Chinese therapeutic company Pediatrix Therapeutics, Inc. announced that the companies have entered into a license agreement.

Under the license agreement, Aclaris has granted Pediatrix the exclusive rights to develop, manufacture and commercialize ATI-1777, Aclaris' investigational "soft" Janus kinase (JAK) 1/3 inhibitor, for any disease, including atopic dermatitis, in Greater China (Mainland China, Hong Kong, Macau and Taiwan).

Aclaris will retain the rights to develop, manufacture and commercialize ATI-1777 in the rest of the world.

Under the terms of the agreement, Aclaris will receive an upfront payment of $5 million. In addition, Aclaris is eligible to receive milestone payments of up to $91 million if certain development, regulatory and commercial objectives are achieved.

Aclaris is also eligible to receive a tiered royalty ranging from a low-to-high single digit percentage of net sales of ATI-1777 by Pediatrix in Greater China.

For More Such Health News, visit rttnews.com

read more
CrowdStrike Shares Hit On Q1 Loss, Weak Q2 Adj. EPS View; Despite FY26 Outlook Raise, $1 Bln Buyback

CrowdStrike Shares Hit On Q1 Loss, Weak Q2 Adj. EPS View; Despite FY26 Outlook Raise, $1 Bln Buyback

Shares of CrowdStrike Holdings, Inc. declined around 7 percent in the after-hours trading on Tuesday after the cybersecurity technology company reported a loss in its first quarter, compared to prior year's profit, and guided second-quarter earnings below last year. However, first-quarter revenues climbed, and the firm lifted its fiscal 2026 earnings outlook, but maintained annual revenue view.
RTTNews | Pred 20 minútami
Yen Falls Amid Risk-on Mood

Yen Falls Amid Risk-on Mood

The Japanese yen weakened against other major currencies in the Asian session on Wednesday, as Asian stock markets traded higher on optimism about amicable trade deals being reached between the U.S. and its trade partners over the weekend after the recent uncertainty. Major currencies in the region also strengthened against the US dollar.
RTTNews | Pred 1 h 29 min
European Economic News Preview: Eurozone Final Composite PMI Due

European Economic News Preview: Eurozone Final Composite PMI Due

Composite Purchasing Managers' survey results from Eurozone and the UK are due on Wednesday, headlining a busy day for the European economic news. At 3.00 am ET, Spain's INE publishes Spain's industrial production data for April. At 3.15 am ET, S&P Global releases Spain's services Purchasing Managers' survey results.
RTTNews | Pred 1 h 30 min
European Shares Seen Flat To Higher At Open

European Shares Seen Flat To Higher At Open

European stocks may open flat to slightly higher on Wednesday as investors watch the latest developments on the trade front and look ahead to key events this week, including Thursday's ECB meeting and the release of U.S. non-farm payrolls report o Friday.
RTTNews | Pred 2 h 2 min
Yen Falls Against Majors

Yen Falls Against Majors

The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews | Pred 2 h 7 min
Australian Market Extends Early Gains In Mid-market

Australian Market Extends Early Gains In Mid-market

The Australian stock market is extending its early gains in mid-market moves on Wednesday, adding to the gains in the previous session, with the benchmark S&P/ASX 200 moving well above the 8,500 level, following the broadly positive cues from Wall Street overnight, with gains across most sectors led by energy, financial and technology stocks.
RTTNews | Pred 4 h 0 min